← FDA Drug Approvals (Drugs@FDA)

ERYTHROMYCIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: RENAISSANCE PHARMA · Approved 1997-02-14

Drug application

FDA Application #

ANDA064127

Application type

Abbreviated New Drug Application (Generic)

Brand name

ERYTHROMYCIN

Generic name

Erythromycin

Active ingredients

ERYTHROMYCIN

Dosage form

SOLUTION

Route

TOPICAL

Marketing status

Discontinued

Sponsor

RENAISSANCE PHARMA

First approval

1997-02-14

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown